164 related articles for article (PubMed ID: 27792106)
21. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
Dubory A; Missenard G; Domont J; Court C
Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
23. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
[TBL] [Abstract][Full Text] [Related]
24. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.
Urakawa H; Mizusawa J; Tanaka K; Eba J; Hiraga H; Kawai A; Nishida Y; Hosaka M; Iwamoto Y; Fukuda H; Ozaki T
Jpn J Clin Oncol; 2019 Apr; 49(4):379-382. PubMed ID: 30796832
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
Puri A; Gulia A; Hegde P; Verma V; Rekhi B
Bone Joint J; 2019 Feb; 101-B(2):170-177. PubMed ID: 30700112
[TBL] [Abstract][Full Text] [Related]
26. Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base.
Sekar A; Rudrappa S; Gopal S; Ghosal N; Gupta V; Ts L
World Neurosurg; 2018 Nov; 119():97-102. PubMed ID: 30075260
[TBL] [Abstract][Full Text] [Related]
27. Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme.
Erdogan KE; DevecI MA; Paydas S; Gonlusen G
Pol J Pathol; 2016; 67(4):392-397. PubMed ID: 28547968
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
Urakawa H; Yonemoto T; Matsumoto S; Takagi T; Asanuma K; Watanuki M; Takemoto A; Naka N; Matsumoto Y; Kawai A; Kunisada T; Kubo T; Emori M; Hiraga H; Hatano H; Tsukushi S; Nishida Y; Akisue T; Morii T; Takahashi M; Nagano A; Yoshikawa H; Sato K; Kawano M; Hiraoka K; Tanaka K; Iwamoto Y; Ozaki T
World J Surg Oncol; 2018 Aug; 16(1):160. PubMed ID: 30089488
[TBL] [Abstract][Full Text] [Related]
29. How safe and effective is denosumab for bone giant cell tumour?
Errani C; Tsukamoto S; Mavrogenis AF
Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421
[TBL] [Abstract][Full Text] [Related]
30. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
31. Role of denosumab before resection and reconstruction in giant cell tumors of bone: a single-centered retrospective cohort study.
Sahito B; Ali SME; Kumar D; Kumar J; Hussain N; Lakho T
Eur J Orthop Surg Traumatol; 2022 Apr; 32(3):567-574. PubMed ID: 34050817
[TBL] [Abstract][Full Text] [Related]
32. Giant cell tumor of bone.
Mendenhall WM; Zlotecki RA; Scarborough MT; Gibbs CP; Mendenhall NP
Am J Clin Oncol; 2006 Feb; 29(1):96-9. PubMed ID: 16462511
[TBL] [Abstract][Full Text] [Related]
33. A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab.
Yang Y; Li Y; Liu W; Xu H; Niu X
Medicine (Baltimore); 2018 Nov; 97(46):e13139. PubMed ID: 30431583
[TBL] [Abstract][Full Text] [Related]
34. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab.
Rosa D; Dias RB; Salvador JC; Borges A
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30196254
[TBL] [Abstract][Full Text] [Related]
35. Giant cell tumors of the spine: has denosumab changed the treatment paradigm?
Goldschlager T; Dea N; Boyd M; Reynolds J; Patel S; Rhines LD; Mendel E; Pacheco M; Ramos E; Mattei TA; Fisher CG
J Neurosurg Spine; 2015 May; 22(5):526-33. PubMed ID: 25700239
[TBL] [Abstract][Full Text] [Related]
36. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection?
Sambri A; Medellin MR; Errani C; Campanacci L; Fujiwara T; Donati D; Parry M; Grimer R
J Orthop Sci; 2020 May; 25(3):513-519. PubMed ID: 31155442
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
[TBL] [Abstract][Full Text] [Related]
38. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
Urakawa H; Nagano A; Machida R; Tanaka K; Kataoka T; Sekino Y; Nishida Y; Takahashi M; Kunisada T; Kawano M; Yoshida Y; Takagi T; Sato K; Hiruma T; Hatano H; Tsukushi S; Sakamoto A; Akisue T; Hiraoka K; Ozaki T
Jpn J Clin Oncol; 2022 Sep; 52(9):1021-1028. PubMed ID: 35472141
[TBL] [Abstract][Full Text] [Related]
39. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
[TBL] [Abstract][Full Text] [Related]
40. [Treatment progress on giant cell tumors of bone].
Liang P
Zhongguo Gu Shang; 2018 Mar; 31(3):292-296. PubMed ID: 29600686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
